Pfizer Cutting 600 Jobs in St Louis

Pfizer is cutting 600 jobs in St Louis as part of a restructuring being done in the wake of its purchase of drug and vaccine maker Wyeth. Pfizer acquired Wyeth in mid October and is consolidating its R&D program company wide. Some layoffs will occur immediately with the rest spread out through 2011. The remaining workforce a the St Louis R&D center will focus on biotherapeutics.

Phizer, which is based in New York, is the number one pharmaceutical company in the world ranked by total sales.